IL106953A0 - Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions - Google Patents
Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositionsInfo
- Publication number
- IL106953A0 IL106953A0 IL106953A IL10695393A IL106953A0 IL 106953 A0 IL106953 A0 IL 106953A0 IL 106953 A IL106953 A IL 106953A IL 10695393 A IL10695393 A IL 10695393A IL 106953 A0 IL106953 A0 IL 106953A0
- Authority
- IL
- Israel
- Prior art keywords
- adsorbate
- preparation
- pharmaceutical compositions
- active compound
- solid active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4230371 | 1992-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL106953A0 true IL106953A0 (en) | 1993-12-28 |
Family
ID=6467712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL106953A IL106953A0 (en) | 1992-09-11 | 1993-09-09 | Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0587137A1 (es) |
| JP (1) | JPH06192093A (es) |
| KR (1) | KR940006583A (es) |
| AU (1) | AU663000B2 (es) |
| CA (1) | CA2105913A1 (es) |
| FI (1) | FI933954A (es) |
| HU (1) | HUT67577A (es) |
| IL (1) | IL106953A0 (es) |
| MX (1) | MX9305578A (es) |
| NO (1) | NO933237L (es) |
| NZ (1) | NZ248627A (es) |
| TW (1) | TW222585B (es) |
| ZA (1) | ZA936695B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3733140B2 (ja) * | 1993-06-04 | 2006-01-11 | ワーナー−ランバート・コンパニー | 多重作用性風邪／鼻づまり製剤 |
| US5626878A (en) * | 1995-01-10 | 1997-05-06 | Warner Lambert Company | Reduction of electrostatic forces between magnesium trisilicate adsorbates |
| CZ20012201A3 (cs) * | 1998-12-18 | 2001-09-12 | Abbott Laboratories | Přípravek s řízeným uvolňováním obsahující divalproex sodný |
| CA2572180C (en) * | 2004-06-28 | 2014-05-20 | Lifecycle Pharma A/S | Porous tablets as carriers for liquid formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2879161A (en) * | 1956-05-14 | 1959-03-24 | American Cyanamid Co | Stable dry powder compositions containing choline chloride and methods of preparing same |
| DE3409063A1 (de) * | 1984-03-13 | 1985-09-19 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern |
| DE3924093A1 (de) * | 1989-07-20 | 1991-02-07 | Hoechst Ag | N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
| GB9025251D0 (en) * | 1990-11-20 | 1991-01-02 | Solomon Montague C | Nifedipine dosage forms |
-
1993
- 1993-03-02 TW TW082101487A patent/TW222585B/zh active
- 1993-09-08 EP EP93114413A patent/EP0587137A1/de not_active Withdrawn
- 1993-09-09 IL IL106953A patent/IL106953A0/xx unknown
- 1993-09-09 KR KR1019930018067A patent/KR940006583A/ko not_active Application Discontinuation
- 1993-09-09 HU HU9302555A patent/HUT67577A/hu unknown
- 1993-09-09 NZ NZ248627A patent/NZ248627A/xx unknown
- 1993-09-09 FI FI933954A patent/FI933954A/fi not_active Application Discontinuation
- 1993-09-10 MX MX9305578A patent/MX9305578A/es not_active Application Discontinuation
- 1993-09-10 JP JP5225707A patent/JPH06192093A/ja active Pending
- 1993-09-10 ZA ZA936695A patent/ZA936695B/xx unknown
- 1993-09-10 AU AU46262/93A patent/AU663000B2/en not_active Ceased
- 1993-09-10 CA CA002105913A patent/CA2105913A1/en not_active Abandoned
- 1993-09-10 NO NO933237A patent/NO933237L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI933954A (fi) | 1994-03-12 |
| HU9302555D0 (en) | 1993-11-29 |
| CA2105913A1 (en) | 1994-03-12 |
| NZ248627A (en) | 1995-01-27 |
| MX9305578A (es) | 1994-03-31 |
| NO933237L (no) | 1994-03-14 |
| NO933237D0 (no) | 1993-09-10 |
| ZA936695B (en) | 1994-04-05 |
| AU4626293A (en) | 1994-03-17 |
| EP0587137A1 (de) | 1994-03-16 |
| JPH06192093A (ja) | 1994-07-12 |
| KR940006583A (ko) | 1994-04-25 |
| HUT67577A (en) | 1995-04-28 |
| FI933954A0 (fi) | 1993-09-09 |
| AU663000B2 (en) | 1995-09-21 |
| TW222585B (es) | 1994-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2143734B (en) | Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content | |
| IL113818A0 (en) | Pharmaceutical active cns compounds and pharmaceutical compositions containing them | |
| IL105220A0 (en) | Cyclohexanylidene compounds and pharmaceutical compositions containing them | |
| IL107978A0 (en) | Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL105283A0 (en) | Stability-enhanced variants of parathyroid hormone,pharmaceutical compositions containing the same and methods for the preparation thereof | |
| CZ8193A3 (en) | Pharmaceutical dosing form with prolonged release of active compound | |
| IL107771A0 (en) | Pharmaceutical compositions containing isothiourea derivatives certain such novel compounds and their preparation | |
| ZA934090B (en) | Biphenyl derivatives pharmaceutical compositions containing these compounds and processes for preparing them | |
| IL108019A0 (en) | Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them | |
| AU3152993A (en) | Improvements in the administration of aerosol compounds | |
| EP0440809A4 (en) | Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient | |
| AU5100393A (en) | Diindolo compounds and pharmaceutical compositions containing them | |
| SG43083A1 (en) | Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them | |
| AU4480889A (en) | A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant | |
| HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
| IL107611A0 (en) | Steroid compounds and pharmaceutical compositions containing them | |
| IL106953A0 (en) | Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions | |
| ZA933638B (en) | Heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them | |
| AU4532893A (en) | Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use | |
| ZA939195B (en) | Stabilized medicinal aerosol solution formulations | |
| HRP940315B1 (en) | Process for the preparation of pharmaceutical compositions containinbg active ingredient | |
| IL102116A (en) | Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| AP9300542A0 (en) | 17a and 17b-alkylketone-3-carboxyaromatic a ring steroidal compounds and pharmaceutical compositions containing these compounds | |
| AU3526193A (en) | Dosage aerosols containing the active substance flezelastin and related structures | |
| ZA94368B (en) | Amino acid derivatives pharmaceutical compositions containing these compound and processes for their preparation |